Can you provide a comprehensive study guide on dementia for medical students?

Dementia Study Guide for Medical Students

Core Diagnostic Framework

Dementia (major neurocognitive disorder) is diagnosed when cognitive or behavioral symptoms interfere with work or usual activities, represent a documented decline from previous functioning, are not explained by delirium or major psychiatric disorder, and involve impairment in at least two cognitive domains. 1, 2

Three Essential Diagnostic Elements

• Functional impairment: Cognitive or behavioral symptoms must interfere with ability to function at work or usual activities, requiring assistance with complex instrumental activities of daily living such as managing finances or medications 1, 2
• Documented decline: Symptoms must represent a demonstrable decline compared with previous levels of functioning and performance 1, 2
• Exclusion of other causes: Symptoms are not explained by delirium or major psychiatric disorder 1, 2

Five Cognitive Domains (Minimum Two Must Be Impaired)

• Memory: Learning and recall of recently learned information 1, 2
• Executive function: Reasoning, judgment, and problem-solving abilities 1, 2
• Visuospatial abilities: Spatial cognition, object recognition, face recognition 1, 2
• Language: Word-finding, comprehension, expression 1, 2
• Behavioral/personality: Changes in comportment, personality alterations 1, 2

Diagnostic Assessment Algorithm

Step 1: Obtain Dual-Source History

• Mandatory requirement: Gather detailed information from BOTH the patient AND a knowledgeable informant, because patients often lack insight into their cognitive, functional, and behavioral changes 1, 2
• Focus specifically on: onset pattern (insidious vs. sudden), progression pattern (gradual vs. stepwise), and impact on instrumental activities of daily living 1
• Use standardized informant tools: ECog, AD8, IQCODE, or Quick Dementia Rating System (QDRS) 2

Step 2: Perform Objective Cognitive Assessment

• First-line screening tools: Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE) 2
• Rapid screening alternatives: Memory Impairment Screen (MIS) + Clock Drawing Test, Mini-Cog, AD8 questionnaire, or Four-item version of MoCA 2
• When to escalate: Order formal neuropsychological testing when routine history and bedside examination do not yield a confident diagnosis 1

Step 3: Differentiate from Mild Cognitive Impairment (MCI)

The critical distinction is functional independence:

• MCI: Subjective cognitive concern with objective impairment in one or more domains BUT preserved independence in functional abilities (may have mild difficulty with complex tasks only) 1
• Dementia: Significant interference with ability to function at work or usual daily activities 1, 2

Alzheimer's Disease: Clinical Diagnosis

Probable AD Dementia Criteria

A diagnosis of probable AD dementia requires meeting general dementia criteria PLUS the following characteristics: 3

Temporal Pattern (Essential)

• Insidious onset: Symptoms develop gradually over months to years, NOT suddenly over hours or days 3, 4
• Clear-cut history of worsening: Progressive decline documented by report or observation 3, 4
• Steady, continuously worsening course: No abrupt changes or stepwise deterioration 4

Clinical Presentations

Amnestic presentation (most common): 3, 1

• Prominent impairment in learning and recall of recently learned information (hippocampal-type memory impairment)
• Evidence of cognitive dysfunction in at least one other cognitive domain

Non-amnestic presentations (especially before age 65): 3, 1

• Language-predominant: Most prominent deficits in word-finding (logopenic primary progressive aphasia), with deficits in other domains present
• Visuospatial-predominant: Most prominent deficits in spatial cognition, object agnosia, impaired face recognition, simultanagnosia, alexia (posterior cortical atrophy)
• Executive dysfunction-predominant: Most prominent deficits in reasoning, judgment, and problem-solving

Exclusion Criteria (When NOT to Diagnose Probable AD)

Do NOT apply probable AD dementia diagnosis when there is evidence of: 3

• Substantial concomitant cerebrovascular disease (history of stroke temporally related to cognitive onset/worsening, multiple/extensive infarcts, or severe white matter hyperintensity burden)
• Core features of dementia with Lewy bodies (other than dementia itself)
• Prominent features of behavioral variant frontotemporal dementia
• Prominent features of semantic variant or non-fluent/agrammatic variant primary progressive aphasia
• Another concurrent active neurological disease or medical comorbidity that could substantially affect cognition

Biomarker Framework for Alzheimer's Disease

Critical Interpretation Rule

BOTH amyloid-β AND tau/neurodegeneration biomarkers must be positive for definitive AD diagnosis; amyloid positivity alone is insufficient because it can occur in Lewy body dementia, vascular cognitive impairment, cerebral amyloid angiopathy, and age-related amyloid accumulation without dementia. 1

Biomarker Categories and Interpretation

Biomarker Type	Positive Finding	Interpretation
Amyloid-β	Low CSF Aβ42 concentration OR positive amyloid PET imaging	Indicates amyloid pathology [4,1]
Tau/Neurodegeneration	Elevated CSF total tau and phosphorylated tau OR reduced FDG uptake on PET in temporoparietal cortex OR disproportionate atrophy on MRI (medial/basal/lateral temporal lobes, medial parietal cortex)	Indicates tau pathology and neurodegeneration [4,1]

Diagnostic certainty based on biomarker combinations: 4

• Both amyloid AND tau positive: High likelihood of AD pathology, increases diagnostic certainty for probable AD
• Both amyloid AND tau negative: Low likelihood of AD pathology, suggests alternative etiology
• Amyloid positive but tau negative: Non-specific finding, insufficient for AD diagnosis 1

When Biomarkers Are Most Valuable

• Clinical picture is atypical or non-amnestic 4
• Mixed pathologies are suspected 4
• Patient is being considered for anti-amyloid immunotherapies or clinical trials 3

Differential Diagnosis: Key Distinguishing Features

Vascular Dementia

• Temporal pattern: Sudden onset or stepwise deterioration (NOT insidious and gradual) 4
• Vascular events: History of stroke temporally linked to cognitive decline 3, 4
• Imaging findings: Multiple/extensive infarcts or severe white matter hyperintensity burden 3, 4
• Epidemiology: Pure vascular dementia represents approximately 15% of all dementia cases, with mixed vascular and degenerative dementia accounting for an additional 16% 5

Dementia with Lewy Bodies

• Motor signs: Early parkinsonism (rigidity, bradykinesia, tremor) helps differentiate from AD 4
• Core features: Visual hallucinations, fluctuating cognition, REM sleep behavior disorder 3
• Biomarker caveat: May have positive amyloid biomarkers, emphasizing need for tau confirmation for AD diagnosis 1

Frontotemporal Dementia (Behavioral Variant)

• Age of onset: Usually presents at younger age (often before 65) 4
• Behavioral changes: Prominent behavioral disinhibition, personality alteration, apathy, loss of empathy 3, 4
• Language variants: Semantic variant (loss of word meaning) or non-fluent/agrammatic variant (effortful speech, grammar errors) 3
• Memory pattern: Memory is relatively preserved early in the disease course, unlike AD 3

Common Diagnostic Pitfalls and How to Avoid Them

Pitfall 1: Assuming Memory Impairment Always Equals AD

Avoidance strategy: Memory impairment is NOT always the primary deficit in dementia; non-amnestic presentations occur frequently, particularly with onset before age 65, including language-predominant, visuospatial-predominant, or executive dysfunction-predominant presentations 1, 2

Pitfall 2: Misinterpreting Executive Dysfunction as Frontotemporal Dementia

Avoidance strategy: Executive dysfunction should NOT be automatically interpreted as frontotemporal dementia; it is a well-documented non-amnestic presentation of AD, and the 2025 NIA-AA criteria explicitly recognize executive, language, and visuospatial presentations as valid AD phenotypes 4

Pitfall 3: Diagnosing Vascular Dementia Based Solely on Age and Vascular Risk Factors

Avoidance strategy: The temporal pattern (insidious vs. sudden/stepwise) is essential for accurate differentiation; insidious onset with gradual progression over months-to-years distinguishes AD from vascular dementia 4

Pitfall 4: Relying Solely on Amyloid Biomarkers

Avoidance strategy: Amyloid positivity alone is non-specific and can occur in cerebral amyloid angiopathy, Lewy body dementia, and age-related changes; BOTH amyloid and tau positivity must be demonstrated for AD diagnosis 1

Pitfall 5: Relying Only on Patient Self-Report

Avoidance strategy: Always obtain informant corroboration using standardized instruments (ECog, AD8, IQCODE, QDRS) because patients often lack insight into their deficits 2

Pitfall 6: Overlooking MMSE Limitations

Avoidance strategy: MMSE has ceiling effects in highly educated individuals and floor effects in those with low education; MoCA is generally preferred for detecting mild cognitive impairment and early dementia 2

Pitfall 7: Confusing Dementia with Primary Psychiatric Disorders

Avoidance strategy: Psychiatric symptoms are extremely common in dementia and can be the presenting feature (more than half of patients who develop dementia have depression or irritability before cognitive impairment becomes apparent), but dementia is NOT a psychiatric disorder; actively exclude primary psychiatric disorders through rigorous application of DSM-5 criteria, and consider psychiatry consultation when behavioral variant FTD is on the differential 1

Syndromic vs. Etiologic Diagnosis Framework

Understanding the Relationship

• Syndromic diagnosis: Defined by the nature of the cognitive and/or behavioral domain most prominently impacted 3
• Etiologic diagnosis: The underlying pathologic cause (AD, vascular, Lewy body, frontotemporal lobar degeneration, etc.) 3
• Critical concept: There is a probabilistic—NOT deterministic—relationship between syndromic and etiologic diagnosis 3

Mixed Pathologies

• AD neuropathologic changes can be associated with many clinical syndromes 3
• Multiple etiologies are likely in individuals older than 85 years 3
• Vascular contributions to cognitive impairment and dementia (VCID) may be the primary etiology or a contributor to a host of syndromes 3

Clinical Judgment in Diagnostic Boundaries

Distinguishing normal cognition, MCI, and dementia often lacks sharp demarcations; clinical judgment is essential for accurate classification, integrating history from patient and informant, objective testing, functional assessment, and biomarker data when available. 1